| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/08/1997 | US5645829 Mesothelial cell gene therapy |
| 07/08/1997 | US5645820 Treatment of autoimmune diseases by aerosol administration of autoantigens |
| 07/05/1997 | CA2194411A1 Staphylococcus aureus polynucleotides and sequences |
| 07/03/1997 | WO1997023783A1 Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
| 07/03/1997 | WO1997023729A1 Polymers responsive to electrical energy |
| 07/03/1997 | WO1997023644A1 The pig myogenin gene and method to identify polymorphisms related to muscle growth |
| 07/03/1997 | WO1997023642A1 Size-based marker identification technology |
| 07/03/1997 | WO1997023640A1 Human chemotactic cytokine i |
| 07/03/1997 | WO1997023639A1 Process for producing biologically active fused proteins |
| 07/03/1997 | WO1997023638A1 Method for refolding human activin a |
| 07/03/1997 | WO1997023636A1 Production of recombinant baculoviruses |
| 07/03/1997 | WO1997023633A1 Improved methods for transforming phaffia strains, transformed phaffia strains so obtained and recombinant dna in said methods |
| 07/03/1997 | WO1997023632A1 A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 AND ITS ASSOCIATION WITH minK |
| 07/03/1997 | WO1997023631A2 Globins containing binding domains |
| 07/03/1997 | WO1997023629A1 A novel receptor-type tyrosine kinase and use thereof |
| 07/03/1997 | WO1997023626A1 Helicobacter pylori oxidoreductase enzymes and their uses |
| 07/03/1997 | WO1997023624A2 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 07/03/1997 | WO1997023623A1 Component of a staphylococcus signal transduction system |
| 07/03/1997 | WO1997023622A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023621A1 Component of a staphylococcus signal transduction system |
| 07/03/1997 | WO1997023620A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023619A1 Sequences coding for new bacteriocins |
| 07/03/1997 | WO1997023618A1 Dna sequences coding for a protein conferring male sterility |
| 07/03/1997 | WO1997023617A1 Antimicrobial proteins |
| 07/03/1997 | WO1997023616A1 Polypeptides with interleukin 16 activity, process for the preparation and use thereof |
| 07/03/1997 | WO1997023615A1 Multimer forms of interleukin-16 (il-16), process for the preparation and use thereof |
| 07/03/1997 | WO1997023614A1 Osteoprotegerin |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |
| 07/03/1997 | WO1997023612A2 Targeted compounds with cartilage formation-inducing and/or bone formation-inducing activity |
| 07/03/1997 | WO1997023611A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | WO1997023610A1 Dna sequences associated with fraxe mental retardation |
| 07/03/1997 | WO1997023600A1 A conjugate vaccine against gram-negative bacterial infections |
| 07/03/1997 | WO1997023598A2 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 07/03/1997 | WO1997023597A2 Process for the microbial production of amino acids by boosted activity of export carriers |
| 07/03/1997 | WO1997023508A1 Compounds with growth hormone releasing properties |
| 07/03/1997 | WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | WO1997023506A1 Two-component signal tranducing system from staphylococcus aureus |
| 07/03/1997 | WO1997023505A1 Two component signal transducing system protein from staphylococcus aureus |
| 07/03/1997 | WO1997023504A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |
| 07/03/1997 | WO1997023503A1 Vaccine component |
| 07/03/1997 | WO1997023502A1 Plasmid vaccine for pseudorabies virus |
| 07/03/1997 | WO1997023501A1 Therapeutic compositions |
| 07/03/1997 | WO1997023500A1 Endothelial cell proliferation inhibitor and method of use |
| 07/03/1997 | WO1997023236A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | WO1997023235A1 Anti-lps factor from horseshoe crabs and methods of use |
| 07/03/1997 | WO1997023231A1 Novel use of compositions containing mother-of-pearl |
| 07/03/1997 | WO1997023129A1 Model transgenic animal for interleukin-1 relevant diseases |
| 07/03/1997 | WO1997018238A3 Crf analogs |
| 07/03/1997 | WO1997018232A3 Peptides derived from the oncogene proteine bcr-abl expressed by leukemic cells and utilisation thereof for the therapy of human leukemiae |
| 07/03/1997 | CA2241924A1 Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
| 07/03/1997 | CA2241129A1 Therapeutic compositions |
| 07/03/1997 | CA2241023A1 Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 07/03/1997 | CA2240968A1 Dna sequences coding for a protein conferring male sterility |
| 07/03/1997 | CA2240739A1 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 07/03/1997 | CA2239909A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | CA2239812A1 The pig myogenin gene and method to identify polymorphisms related to muscle growth |
| 07/03/1997 | CA2239711A1 Compounds with growth hormone releasing properties |
| 07/03/1997 | CA2239704A1 Polypeptides with interleukin 16 activity, process for the preparation and use thereof |
| 07/03/1997 | CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | CA2239303A1 Globins containing binding domains |
| 07/03/1997 | CA2238967A1 Antimicrobial proteins |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/03/1997 | CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | CA2216308A1 Plasmid vaccine for pseudorabies virus |
| 07/03/1997 | CA2214095A1 Novel use of compositions containing mother-of-pearl |
| 07/03/1997 | CA2213512A1 Method for producing bioactive fusion protein |
| 07/02/1997 | EP0781849A1 Tissue-specific promoter |
| 07/02/1997 | EP0781848A2 Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein |
| 07/02/1997 | EP0781846A2 Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen |
| 07/02/1997 | EP0781845A2 Anti-human milk fat globule humanised antibodies and processes for their production |
| 07/02/1997 | EP0781844A1 Gene participating in apoptosis |
| 07/02/1997 | EP0781779A2 Nonantigenic stabilizer and physiologically active substance |
| 07/02/1997 | EP0781558A2 Pharmaceutical use of heparin cofactor II |
| 07/02/1997 | EP0781347A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 07/02/1997 | EP0781343A1 Retroviral vector hybrids and the use thereof for gene transfer |
| 07/02/1997 | EP0781342A1 Phytopathogenic dna virus resistant transgenic plants and seeds and methods for obtaining same |
| 07/02/1997 | EP0781341A1 Method for the production of recombinant proteins, plasmids and modified cells |
| 07/02/1997 | EP0781340A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/02/1997 | EP0781338A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG |
| 07/02/1997 | EP0781336A1 A human map kinase homolog |
| 07/02/1997 | EP0781335A1 Cloning and characterizing of genes associated with long-term memory |
| 07/02/1997 | EP0781334A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 07/02/1997 | EP0781333A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 07/02/1997 | EP0781331A1 Improvements in or relating to binding proteins for recognition of dna |
| 07/02/1997 | EP0781329A1 Overexpression of mammalian and viral proteins |
| 07/02/1997 | EP0781326A1 The irs family of genes |
| 07/02/1997 | EP0781297A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
| 07/02/1997 | EP0781296A1 ACTIVE INDUCTION OR PASSIVE IMMUNIZATION OF ANTI-gp48 ANTIBODIES AND ISOLATED gp48 PROTEIN |
| 07/02/1997 | EP0781295A1 Asp b1 insulin analogs |
| 07/02/1997 | EP0781294A1 Metal-containing ribonucleotide polypeptides |
| 07/02/1997 | EP0781143A1 Method of blocking the sec receptor |
| 07/02/1997 | EP0781142A1 Compositions and methods for delivery of polypeptides |
| 07/02/1997 | EP0781140A1 Corticotropin release inhibiting factor and methods of using same |
| 07/02/1997 | EP0781139A1 Intracellular delivery of chemical agents to a specific cell type |
| 07/02/1997 | EP0781095A1 Cells bearing cd4 decoy receptors and related molecules and methods |
| 07/02/1997 | EP0781092A1 Method of sensitizing tumor cells with adenovirus e1a |
| 07/02/1997 | EP0702720A4 Method for defined deletions of dna |
| 07/02/1997 | EP0689552A4 A method of detecting rupture of the amniotic membranes in pregant mammals |
| 07/02/1997 | EP0629347B1 Antibacterial agent and treatment of article therewith |
| 07/02/1997 | EP0627000A4 Mammalian expression systems for hcv proteins. |